It does not harm any surrounding tissue, delivering controlled cooling safely into the fat cells
FDA currently lists BPC-157 among compounding substances for which it has identified potential immunogenicity, peptide-impurity, and API-characterization concerns, while noting that it has limited safety information for proposed routes of administration
The compound shows high enzymatic selectivity, preserves lean mass, and engages longevity-related pathways (e.g., SIRT1), but remains a nonFDA-approved research substance that is WADA-banned and should be used under medical guidance
Heal + strengthen your skin with medical-grade peptide therapy at Mousai Wellness Sukhumvit 39
Suggested dosage for cattle, horses, sheep, and swine is 1 to 2 ml